Tracked deals
5
5 tracked deals across 2021-2026.
Minneapolis, Minnesota, United States
A global healthcare technology leader providing innovations across major clinical areas through medical devices, therapies, and services.
Tracked deals
5
5 tracked deals across 2021-2026.
Recent pace
3
3 tracked deals announced in the last 12 months.
Deal mix
Buyout
4 buyout · 1 divestiture
Last 3 years
Supporting Data
Medtronic agreed to acquire SPR Therapeutics for approximately $650 million in cash to add SPR’s FDA-cleared Sprint (SPRINT) temporary peripheral nerve stimulation (PNS) technology to its neuromodulation/pain portfolio. Medtronic later completed the acquisition, integrating the SPRINT PNS System to expand minimally invasive, non-opioid chronic and acute pain treatment options.
Medtronic plc has completed its acquisition of CathWorks, a privately held medical device company focused on transforming how coronary artery disease is diagnosed and treated. The deal is valued at $585 million, with potential undisclosed earn-out payments, and enhances Medtronic’s interventional cardiology portfolio via the CathWorks FFRangio System.
Medtronic entered into a definitive agreement to acquire Scientia Vascular in a $550 million deal, with customary adjustments and potential earn-out/milestone payments. The acquisition combines Scientia’s neurovascular access devices (guidewires and catheters) with Medtronic’s existing neurovascular therapeutic portfolio to support faster and more reliable treatment for complex stroke cases.
Medtronic plc acquired certain nano surface technology assets and related IP rights from Columbia City, Indiana-based Nanovis to support development of next-generation PEEK interbody fusion devices. Financial terms were not disclosed; the deal transfers Nanovis’ bone-growth nanotechnology (including rights related to Sites Medical’s OsteoSync titanium pads) to Medtronic for integration into its spinal implant portfolio.
Medtronic plc acquired SonarMed, a Purdue‑bred developer of the SonarMed airway monitoring system, in December 2020. The acquisition adds continuous acoustic airway monitoring technology for neonatal and pediatric ventilation to Medtronic's respiratory/medical surgical portfolio to help detect endotracheal tube obstruction and position in real time.
Turn tracked acquisition activity into an outreach-ready buyer list.